(Q38977601)

8 September 2017

title

Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer (English)

1 reference

8 September 2017

1 reference

2

Naohiko Seki

1 reference

8 September 2017

13

Hideki Enokida

1 reference

8 September 2017

Satoru Inoguchi

1

1 reference

8 September 2017

Takeshi Chiyomaru

3

1 reference

8 September 2017

Tomoaki Ishihara

4

1 reference

8 September 2017

Ryosuke Matsushita

5

1 reference

8 September 2017

Hiroko Mataki

6

1 reference

8 September 2017

Toshihiko Itesako

7

1 reference

8 September 2017

Shuichi Tatarano

8

1 reference

8 September 2017

Hirofumi Yoshino

9

1 reference

8 September 2017

Yusuke Goto

10

1 reference

8 September 2017

Rika Nishikawa

11

1 reference

8 September 2017

Masayuki Nakagawa

12

1 reference

8 September 2017

language of work or name

English

0 references

publication date

3 July 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

588

1 reference

8 September 2017

issue

17

1 reference

8 September 2017

page(s)

3170-3179

1 reference

8 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

New therapeutic challenges in advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Gene regulation by transcription factors and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

MicroRNAs in cancer: small molecules with a huge impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Metanestin, a glycoprotein with metastasis-associated expression in transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

The functional significance of miR-1 and miR-133a in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

FOX(M1) news--it is cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

FoxM1: a master regulator of tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

A new target for proteasome inhibitors: FoxM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.06.058

10.1016/J.FEBSLET.2014.06.058

21 January 2018

Identifiers

DOI

1 reference

release_s6b2b6h6mbgxzcnaeoj3spec7y

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s6b2b6h6mbgxzcnaeoj3spec7y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference